The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of the Huntingtin gene (HD gene), comprising an antisense strand having a nucleotide sequence which is less than 25 nucleotides in length and which is substantially complementary to at least a part of the HD gene. The invention also relates to a pharmaceutical composition comprising the dsRNA together with a pharmaceutically acceptable carrier; methods for treating diseases caused by the expression of the HD gene, or a mutant form thereof, using the pharmaceutical composition; and methods for inhibiting the expression of the huntingtin gene in a cell.

 
Web www.patentalert.com

< Protected catalytic composition and its preparation and use for preparing polymers from ethylenically unsaturated monomers

< Peptides for targeting the prostate specific membrane antigen

> Heterotricyclic metalloprotease inhibitors

> Fused heteroaryl derivatives and their use as p38 kinase inhibitors

~ 00620